Doxycycline hyclate 100 MG VLS
Ended Awarded
- Contract number
- SPE2D325F214V
- Awardee
-
Hikma Pharmaceuticals USA Inc. UEI NQJ5E87TKNB1 Part of Hikma Specialty USA Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,590
Award facts
- Contract value 100% obligated
- $1,589.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Berkeley Heights, NJ 07922, USA
Award details come from SAM.gov/FPDS.
About this award
Hikma Pharmaceuticals USA Inc. (formerly West-Ward Pharmaceuticals) received a delivery order award from the Defense Logistics Agency's Medical Supply Chain on July 14, 2025, for Doxycycline Hyclate 100 mg VLS with a ceiling value of $1,589.67. This is a firm fixed-price delivery order with no small business set-aside designation and an ultimate completion date of July 15, 2025. The pharmaceutical product will be delivered to Berkeley Heights, New Jersey. Hikma is a foreign-owned, for-profit pharmaceutical manufacturer specializing in generic injectable and non-injectable medications that serve critical roles in military and veterans' healthcare systems.
This delivery order likely falls under one of Hikma's two significant indefinite delivery vehicles: either the $38.5 million single-award Blanket Purchase Agreement with the National Acquisition Center or the $216 million multiple-award Federal Supply Schedule contract with the Department of Veterans Affairs, both covering pharmaceuticals and drugs under the Pharmaceuticals and Drugs (FSS-61-IB) schedule. Doxycycline hyclate is a commonly used broad-spectrum antibiotic essential for military medical readiness and veterans' healthcare. The award reflects the company's established capability as a critical supplier of essential medications to federal government healthcare systems and military treatment facilities.
Quick answers
Who was awarded contract SPE2D325F214V?
SPE2D325F214V was awarded to Hikma Pharmaceuticals USA Inc. by Medical Supply Chain (Troop Support) on July 14, 2025.
How much is contract SPE2D325F214V worth?
The government has obligated $1,590 on SPE2D325F214V.
Is contract SPE2D325F214V an order under another contract?
Yes. SPE2D325F214V is a delivery order under SPE2D020D0006, an indefinite delivery contract.
Was contract SPE2D325F214V competed?
The extent of competition for SPE2D325F214V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award